Latest evidence on effective management of chronic lymphocytic leukemia (CLL) using BTK inhibitors in this video from Clinical Care Options (CCO)
Nicole Lamanna, MD, on modifying CLL treatment during COVID-19 pandemic, IVIg as COVID-19 prophylaxis, and the role of BTK inhibition, from CCO
On-demand Webcast featuring experts’ review of evolving strategies for optimal treatment of patients with relapsed/refractory multiple myeloma in 2020
Download this slideset from a CCO Live Meeting Series to review the latest evidence on selecting optimal management strategies for follicular lymphoma
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.